Epilepsy, Generalized D004829

Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Epilepsy » Epilepsy, Generalized

Description

Recurrent conditions characterized by epileptic seizures which arise diffusely and simultaneously from both hemispheres of the brain. Classification is generally based upon motor manifestations of the seizure (e.g., convulsive, nonconvulsive, akinetic, atonic, etc.) or etiology (e.g., idiopathic, cryptogenic, and symptomatic). (From Mayo Clin Proc, 1996 Apr;71(4):405-14)   MeSH

Hierarchy View

Subtype Terms (5)

Epilepsies, Myoclonic
10 drugs (6 approved, 4 experimental)

Epilepsy, Absence
8 approved drugs

Epilepsy, Tonic-Clonic
5 drugs (4 approved, 1 experimental)

Nodding Syndrome
4 approved drugs

Spasms, Infantile
16 drugs (11 approved, 5 experimental)


Approved Indicated Drugs (2)

Phase 4 Indicated Drugs (2)

Phase 3 Indicated Drugs (2)

Other Experimental Indicated Drugs (1)


Organization Involved with Phase 4 Indications (2)

Organization Involved with Phase 3 Indications (5)

Organization Involved with Phase 2 Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.